We further outline a biomarker-guided stratification strategy integrating tissue-based and liquid biopsy readouts, including circulating tumor DNA, exosomal PD-L1, and redox-responsive microRNAs, to enable dynamic monitoring of tumor redox states during treatment. The gene discussed is CD274; the disease is neoplasm.